Daly James M

Daly James M is listed in filings as Director at ACADIA Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Jun 1, 2026, including sale activity. Recent filings connect the profile to ACADIA Pharmaceuticals Inc. (ACAD) and Cytokinetics, Incorporated - Common Stock (CYTK). The current snapshot covers public activity from Jun 2, 2025 to Jun 1, 2026. Reported amounts are shown as $346.6K to $12.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.